MedPath

: Serial sero-epidemiological surveillance study to monitor the trend of SARS-CoV-2, Dengue and Chikungunya infection transmission in the Vellore Demographic Health Surveillance System (HDSS)

Not Applicable
Registration Number
CTRI/2020/12/029564
Lead Sponsor
Dr Winsley Rose
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

all individuals currently residing and likely to stay in the area till the end of study (1 year) in the study area will be considered eligible for inclusion.

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
I.Estimate the sero-prevalence of SARS-CoV-2 infection in the general population <br/ ><br>II.Estimate the 4 monthly incidence of SARS-CoV-2 infection based on serial sero-surveys <br/ ><br>III.Estimate cumulative sero-conversion of SARS-CoV-2 infection over one year period <br/ ><br>IV.Estimate the sero-prevalence and annual sero conversion of Dengue and Chikungunya in a sub sample of the study <br/ ><br>Timepoint: serosurvey will be done once in 3 months for a period of one year
Secondary Outcome Measures
NameTimeMethod
I.Monitor the trend of SARS-CoV-2 transmission in the general population <br/ ><br>II.Determine the prevalence and incidence of SARS CoV2 sero-positivity among the members of the households with at least one seropositive individual (clustering of infection at household level)Determine the risk factors for SARS-CoV-2 infection <br/ ><br>III.Determine the duration of persistence of antibodies in individuals tested positive for SARS-CoV-2 infection <br/ ><br>Timepoint: serosurvey will be done once in 3 months for a period of one year
© Copyright 2025. All Rights Reserved by MedPath